199 related articles for article (PubMed ID: 37056760)
1. Current research into A20 mediation of allergic respiratory diseases and its potential usefulness as a therapeutic target.
Liu Y; Xu K; Yao Y; Liu Z
Front Immunol; 2023; 14():1166928. PubMed ID: 37056760
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid and TNF signaling converge at A20 (TNFAIP3) to repress airway smooth muscle cytokine expression.
Sasse SK; Altonsy MO; Kadiyala V; Cao G; Panettieri RA; Gerber AN
Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L421-32. PubMed ID: 27371733
[TBL] [Abstract][Full Text] [Related]
3. A20 (Tnfaip3) expressed in CD4
Yokoyama Y; Tamachi T; Iwata A; Maezawa Y; Meguro K; Yokota M; Takatori H; Suto A; Suzuki K; Hirose K; Yamaguchi N; Honda H; Nakajima H
Biochem Biophys Res Commun; 2022 Nov; 629():47-53. PubMed ID: 36099784
[TBL] [Abstract][Full Text] [Related]
4. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
Das T; Chen Z; Hendriks RW; Kool M
Front Immunol; 2018; 9():104. PubMed ID: 29515565
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.
Mele A; Cervantes JR; Chien V; Friedman D; Ferran C
Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371
[TBL] [Abstract][Full Text] [Related]
6. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
7. A20 attenuates allergic airway inflammation in mice.
Kang NI; Yoon HY; Lee YR; Won M; Chung MJ; Park JW; Hur GM; Lee HK; Park BH
J Immunol; 2009 Jul; 183(2):1488-95. PubMed ID: 19553520
[TBL] [Abstract][Full Text] [Related]
8. A20 at the Crossroads of Cell Death, Inflammation, and Autoimmunity.
Martens A; van Loo G
Cold Spring Harb Perspect Biol; 2020 Jan; 12(1):. PubMed ID: 31427375
[TBL] [Abstract][Full Text] [Related]
9. A20 and Cell Death-driven Inflammation.
Priem D; van Loo G; Bertrand MJM
Trends Immunol; 2020 May; 41(5):421-435. PubMed ID: 32241683
[TBL] [Abstract][Full Text] [Related]
10. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
[TBL] [Abstract][Full Text] [Related]
11. A20, an essential component of the ubiquitin-editing protein complex, is a negative regulator of inflammation in human myometrium and foetal membranes.
Lappas M
Mol Hum Reprod; 2017 Sep; 23(9):628-645. PubMed ID: 28911210
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
13. Regulators of A20 (TNFAIP3): new drug-able targets in inflammation.
Momtazi G; Lambrecht BN; Naranjo JR; Schock BC
Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L456-L469. PubMed ID: 30543305
[TBL] [Abstract][Full Text] [Related]
14. The impact of the cytoplasmic ubiquitin ligase TNFAIP3 gene variation on transcription factor NF-κB activation in acute kidney injury.
Rogers NM; Zammit N; Nguyen-Ngo D; Souilmi Y; Minhas N; Meijles DN; Self E; Walters SN; Warren J; Cultrone D; El-Rashid M; Li J; Chtanova T; O'Connell PJ; Grey ST
Kidney Int; 2023 Jun; 103(6):1105-1119. PubMed ID: 37097268
[TBL] [Abstract][Full Text] [Related]
15. Role of A20/TNFAIP3 deficiency in lupus nephritis in MRL/lpr mice.
Sun L; Zou LX; Han YC; Zhu DD; Chen T; Wang J
Clin Exp Nephrol; 2020 Feb; 24(2):107-118. PubMed ID: 31811410
[TBL] [Abstract][Full Text] [Related]
16. A20 Restricts Inflammatory Response and Desensitizes Gingival Keratinocytes to Apoptosis.
Li Y; Mooney EC; Xia XJ; Gupta N; Sahingur SE
Front Immunol; 2020; 11():365. PubMed ID: 32218782
[TBL] [Abstract][Full Text] [Related]
17. A20 Promotes Ripoptosome Formation and TNF-Induced Apoptosis via cIAPs Regulation and NIK Stabilization in Keratinocytes.
Feoktistova M; Makarov R; Brenji S; Schneider AT; Hooiveld GJ; Luedde T; Leverkus M; Yazdi AS; Panayotova-Dimitrova D
Cells; 2020 Feb; 9(2):. PubMed ID: 32028675
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E δ-tocotrienol inhibits TNF-α-stimulated NF-κB activation by up-regulation of anti-inflammatory A20 via modulation of sphingolipid including elevation of intracellular dihydroceramides.
Yang C; Jiang Q
J Nutr Biochem; 2019 Feb; 64():101-109. PubMed ID: 30471562
[TBL] [Abstract][Full Text] [Related]
19. Bavachin exerted anti-neuroinflammatory effects by regulation of A20 ubiquitin-editing complex.
Wang Y; Yang Z; Wang Q; Ren Y; Wang Q; Li Z
Int Immunopharmacol; 2021 Nov; 100():108085. PubMed ID: 34454289
[TBL] [Abstract][Full Text] [Related]
20. A20 ameliorates inflammatory bowel disease in mice via inhibiting NF-κB and STAT3 activation.
Lee SH; Lee HR; Kwon JY; Jung K; Kim SY; Cho KH; Choi J; Lee HH; Lee BI; Jue DM; Cho ML
Immunol Lett; 2018 Jun; 198():44-51. PubMed ID: 29608924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
